Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/26/4/750/16699306/mdu587.pdf
Reference17 articles.
1. Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel;Fitzpatrick;Eur J Cancer,2014
2. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group;Scher;J Clin Oncol,2008
3. Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST;Costelloe;J Cancer,2010
4. Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy;Halabi;J Natl Cancer Inst,2013
5. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer;De Bono;Clin Cancer Res,2008
Cited by 171 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A comprehensive analysis of the association between anemia and systemic inflammation in older patients with cancer;Supportive Care in Cancer;2023-12-19
2. Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond;Biomolecules;2023-12-18
3. Successful treatment with nivolumab in a patient with unresectable oral squamous cell carcinoma following ineffective chemoradiotherapy;Clinical Case Reports;2023-11-28
4. The 29th Annual Prostate Cancer Foundation Scientific Retreat Report;The Prostate;2023-11
5. Investigating Nutritional and Inflammatory Status as Predictive Biomarkers in Oligoreccurent Prostate Cancer—A RADIOSA Trial Preliminary Analysis;Nutrients;2023-10-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3